Skip to main content
. 2022 Jun 27;10(9):840–850. doi: 10.1016/S2213-2600(22)00186-2

Figure 1.

Figure 1

Trial profile

Anti-S1-RBD=antibody for S1 subunit of SARS-CoV-2 spike protein receptor-binding domain. *Some patients had more than one stated reason for ineligibility.